faCellitate

About:

faCellitate is a life science tools company targeting customers in drug discovery, toxicology, industrial biotech and stem cell research.

Website: https://facellitate.com

Twitter/X: facellitate

Top Investors: R3, HTGF | High-Tech Gruenderfonds, SARSTEDT, Arve Capital, ROI land investment

Description:

faCellitate develops polymeric platforms that aim at supporting cancer and stem cell research, drug discovery, toxicology, and tissue engineering. The platform facilitates cellular interaction, significantly improving cell culture in biological research.

Total Funding Amount:

3.7M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Mannheim, Baden-Wurttemberg, Germany

Founded Date:

2019-01-01

Contact Email:

info(AT)facellitate.com

Founders:

Simon Widmaier

Number of Employees:

11-50

Last Funding Date:

2022-09-07

IPO Status:

Private

Industries: